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Development of simple and inexpensive method for the analysis of gene-specific DNA 
methylation is important for the diagnosis and prognosis of patients in cancer. Herein, we 
report a relatively simple and inexpensive electrochemical method for the sensitive and 
selective detection of gene-specific DNA methylation in oesophageal cancer. The underlying 
principle of the method relies on the affinity interaction between DNA bases and unmodified 
gold electrode. Since the affinity trend of DNA bases towards the gold surface follows as 
adenine; (A) > cytosine (C) > guanine (G)> thymine (T), a relatively larger amount of 
bisulfite-treatedadenine-enriched unmethylated DNA adsorbs on the screen-printed gold 
electrodes (SPE-Au) in comparison to the guanine-enriched methylated sample. The 
methylation levels were (i.e., different level of surface attached DNA molecules due to the 
base dependent differential adsorption pattern) quantified by measuring saturated amount of 
charge-compensating [Ru(NH3)6]
3+ molecules in the surface-attached DNAs by 
chronocoulometry as redox charge of the [Ru(NH3)6]
3+ molecules quantitatively reflects the 
amount of the adsorbed DNA confined at the electrode surface. The assay could successfully 
distinguish methylated and unmethylated DNA sequences at single CpG resolution and as 
low as 10% differences in DNA methylation. In addition, the assay showed fairly good 
reproducibility (% RSD= <5%) with better sensitivity and specificity by analysing various 
levels of methylation in two cell lines and eight fresh tissues samples from patients with 
oesophageal squamous cell carcinoma. Finally, the method was validated with methylation 
specific-high resolution melting curve analysis and Sanger sequencing methodsto study the 
methylation in oesophageal cancer samples. 
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DNA methylation is one of the clinically relevant epigenetic biomarkers that regulate gene 
expression via controlling transcriptional alteration, genomic stability, X chromosome 
inactivation, genomic imprinting and mammalian cell development[1]. Recent studies on 
epigenetic research demonstrate that aberrant DNA methylationplays a critical role in the 
pathophysiology of human cancers including oesophageal squamous cell carcinoma 
(ESCC)[2,3]. For example, gene-specific promoter hypermethylation is an important driver in 
the development and progression of many human cancers viatranscriptional inactivation and 
suppressing of gene function[4-8].More recently, it has also been demonstrated that DNA 
methylation can be used as tumour-specific therapeutic targets in ESCC 
[2].Therefore,sensitive and specific profiling of gene specific DNA methylation in ESCC 
could have potential implication for prediction of prognosis as well as to therapy response in 
clinical settings. 
Until recently, gene specific DNA methylation in ESCC is generally detected via 
methylation specific PCR approaches along with bisulfite sequencing[9,10]. Over the past 
several decades,a variety of molecular biological approaches includingmethylation-sensitive 
single nucleotide-primer extension, methylight, methylation-sensitive high resolution 
melting, enzyme-linked immunosorbent assay (ELISA) based methylation assays, mass 
spectroscopy and fluorescence readout based methodshave been conspicuously exploited to 
quantify the level of the DNA methylation in many human cancers [11-15]. However, most 
of these approaches are relatively simpler and robust but typically require large sample 
volumes, sophisticated instruments, multi-step procedures, hazardous radiolabeling, complex 





external controls for quantitative analysis, background fluorescence interference, high labour 
and bioinformatics costswhich limit their use in routine clinical applications.  
In recent years, much attention has been focused on thedevelopment ofsensitive, 
specific, relatively simple and inexpensive method for the analysis ofDNA methylation using 
electrochemistry, colorimetry, surface plasmon resonance and Raman scattering readouts [17-
22].While most of these readout methods have theirown merits and demerits, electrochemical 
readout offersadditional advantages in clinical diagnosticsapplications due to their relatively 
higher sensitivity and specificity, cost-effectiveness and compatibility with the 
miniaturization[23-25].In these assays, sensor requires a surface-attached capture probe to 
hybridize the complementary target sequence, and form duplex DNA that intercalatively bind 
with a redox-active transition-metal cations (e.g., [Ru(NH3)6]
3+) for the generation of 
electrochemical signals [26-29]. As described in many conventional electrochemical assays 
[30-33], the saturated amount of charge-compensation [Ru(NH3)6]
3+ complex (RuHex) on the 
electrode surface is electrochemically determined, which is directly proportional to the 
number of negatively charged phosphate residues and thereby the surface density of the target 
DNA.  
Previously, we demonstrated the use of direct adsorption of bisulfite treated and 
asymmetric PCR-amplified DNA sequences on to an unmodified gold electrode (without the 
use of complementary capture probe and hybridization step) to quantify the level of DNA 
methylation present in the sequence via measuring the total adsorbed DNA on to the 
electrode surface [34,35]. Since the adsorption (i.e., physisorption) trend of the DNA bases to 
gold surfaces follows as adenine (A) > cytosine (C) > guanine (G)> thymine (T) [36,37], two 
DNA sequences with different methylation patterns (i.e., bisulfite treated adenine-enriched 
unmethylated and guanine-enriched methylated DNA sequences) should have different 





DNA was adsorbed on the gold electrode in comparison to the methylated DNA. In this 
system, we showed that monitoring the Faradaic current generated by the [Fe(CN)6]
3-/4- 
system alone could be used for the interrogation of DNA methylation levelpresent in the 
bisulfite treated samples[34,35]. While this assay is relatively simple, it follows an electron 
transfer kinetic-based mechanism, where density of the DNA sequences at the electrode 
surface should be sufficiently low[31]. Additionally, the risk of false-positive responses at 
low concentration of target is well known when using a detection technique based 
onattenuation of the interfacial electron transfer reaction of a redox process (i.e., “signal-off” 
approach). 
In order to avoid this complexity, in the current study, weexplored whether simply 
monitoring the total charge generated by the electrostatically-attached RuHex onto the 
adsorbed DNA could report on the level of DNA methylation present in samples, where 
generated total redox charge is the function of adsorbed DNA sequences on the electrode 
surface [26-29]. Since in this “signal-on” approach,the charge of the RuHex complex is 
quantitatively reflecting the amount of the adsorbed DNA at the electrode surface[30], the 
electrochemical signal generated by the chronocoulometric (CC) interrogation of DNA-
bound RuHex will give the level of methylation present in the amplified samples.It is also 
important to note that unlike RuHexbased conventional methods [30], the current method 
detects DNA methylation by simply monitoring the adsorbed target DNA on an unmodified 
SPE-Au electrode. Since we use direct adsorption of target DNA on an unmodified electrode 
rather than the conventional biosensing approach of using recognition and transduction 
layers, this method substantially simplifies the detection system by avoiding the complicated 
chemistries underlying each step of the sensor fabrication. 
In this method,we first optimized the adsorption parameters (i.e., adsorption time, pH 





unmodified SPE-Au surface. Then, we detectedthe level of promoter methylation present in 
FAM134B gene in a panel of oesophageal squamous cell carcinoma (ESCC) cell lines and 
tissue samples derived from patients withESSC. We also validated the results with 
methylation specific-high resolution melting (MS-HRM) curve analysis and Sanger 
sequencing. 
 
2. Experimental  
2.1. Genomic DNA preparation 
All reagents and chemicals were analytical grade and purchased from Sigma Aldrich (St 
Louis, MO, USA) unless otherwise noted. UltraPure DNase/RNase-free distilled water was 
obtained from Invitrogen (Carlsbad, CA, USA). Whole genome amplification DNA was 
prepared according to the manufacture’s protocol from REPLI-g whole genome amplification 
kit (Qiagen, Hilden, Germany). Two ESCC cell lines (HKESC-1 and HKESC-4) were kindly 
provided from our research group [38-39].Another ESCC cell line, KYSE-510, purchased 
from Leibniz Institute DSMZ (German collection of microorganisms and cell cultures). 100% 
methylated Jurkat genomic DNA was obtained from New England Biolabs (Ipswich, MA, 
USA). Eight fresh frozen tissue samples from patients with ESCC and two non-neoplastic 
oesophageal tissues (as controls) were recruited for this study. Ethical approval was taken 
from the Griffith University human research ethics committee for the use of these samples 
(GU Ref Nos: MED/19/08/HREC and MSC/17/10/HREC). After histopathological 
confirmation, genomic DNA was purified from all ESCC tissue samples with all prep 
DNA/RNA mini kit (Qiagen, Hilden, Germany), according to the manufacturer’s protocols. 
Blood and cell culture DNA mini kit (Qiagen, Hilden, Germany) was used for the purification 
of DNA from ESCC cell lines. All patients had not received pre-operative were free from 





Mean age group of the patients were 65±14 ranging from 45 to 74 years. Screen-printed gold 
electrodes were acquired from Dropsens (Spain). 
 
2.2. Bisulfite modification 
Bisulfite conversion and purification of the genomic DNA was performed with 
MethylEasyXceed kit (Human Genetic Signatures Pty. Ltd., NSW, Australia) as 
recommended by the manufacturer. DNA quantification and purity was checked via 
Nanodrop Spectrophotometer (BioLab, Ipswich, MA, USA). Concentration of bisulfite 
treated DNA was noted in ng/µL and then stored at -20˚C until use. Approximately 500 ng 
genomic DNA from each samples were the starting amount for the bisulfite treatment. 
 
2.3. DNA quantification 
The DNA copy number normalization of FAM134B (JK1) genes in bisulfite treated cell and 
WGA DNA samples were analysed by the Rotor-Gene Q PCR detection system (Qiagen, 
Hilden, Germany). qRT-PCR was performed in a total volume of 10 µL reaction mixture 
containing 5 µL of 2XSensiMix SYBR No-ROX master mix (Bioline, London, UK), 1 µL of 
each 250 nM primer, and 1 µL of equal concentrated target cell and WGA DNA samples with 
2 µL of nuclease-free water. Thermal cycling programs encompassed initial denaturation and 
activate the hot start DNA polymerase in one cycle of 7 minutes at 95 °C followed by 40 
cycles of 10 seconds at 95°C (denaturation), 30 seconds at 60°C (annealing) and 20 seconds 
at 72°C (extension). 
 
2.4. Asymmetric PCR 
Asymmetric PCR of the bisulfite treated DNA was carried out using AmpliTaq Gold 360 





Asymmetric PCR was performed by suing 60 µL reaction mixtures comprising 30 µL of 
AmpliTaq Gold 360 master mix, 1 µL of 125 nM forward primer and 375 nm reverse primer, 
1 µL of 30 ng bisulfite treated DNA and 28 µL of nuclease-free water. PCR cycling programs 
was performed under the following conditions: 95°C for 10 minutes followed by 49 cycles of 
30 seconds at 95°C (denaturation), 30 seconds at 61°C (annealing) and 20 seconds at 72°C 
(extension). 
 
2.5. Determination of the surface area of the electrodes 
Screen-printed electrode with the three-electrode system printed on a ceramic substrate 
(length 33 × width 10 × height 0.5 mm) were purchased from Dropsens (Spain).  In the three-
electrode system, working (SPE-Au, diameter = 4 mm), counter and reference electrodes 
were gold, platinum, and silver-modified electrodes. The effective working area of the 
electrodes were determined under cyclic voltammetric conditions for the one-electron 
reduction of K3[Fe(CN)6] [2.0 mM in water (0.5 M KCl)] and use of the Randles-Sevcikeqn 
(1), 
ip = (269 × 10
5) n3/2AD1/2 Cν1/2 ... ... ... … … (1) 
 
whereip is the peak current (A), n is the number of electrons transferred (Fe
3+ → Fe2+, n = 
1),A is the effective area of the electrode (cm2), D is the diffusion coefficient of [Fe(CN)6]3- 
(taken to be 7.60 × 10-5cm2s-1), C is the concentration (mol cm-3), ν is the scan rate (Vs-1). 
 
2.6. Electrochemical measurements of DNA methylation 
All electrochemical measurements were performed on a CH1040C potentiostat (CH 
Instruments, TX, USA). Cycleicvoltammetric (CV) experiments were performed in 10 mM 





were obtained in 10mM tris buffer (pH 7.4) in the presence and absence of 50 µM RuHex 
with a potential step of 5 mV and pulse width of 250 ms, and sample interval of 2 ms. For 
synthetic DNA samples, 5 μL (diluted in SSC5X buffer to get 100 nM of DNA) sample was 
adsorbed on SPE-Au surface. For clinical samples analysis, 5 μL (diluted in SSC5X buffer to 
get 50 ng of DNA) were used for adsorption experiments. The electrodes were then washed 
three times with PBS prior to perform CC readouts. The total redox charge (Qtotal) 
corresponding to RuHex electrostatically bound to the surface localized DNA was calculated 
usingEq. 2. 
𝑄𝑡𝑜𝑡𝑎𝑙 = 𝑄𝑡𝑎𝑟𝑔𝑒𝑡 − 𝑄𝑑𝑙 ….  … . … . … . … . ….  (2)  
where Qtargetis the charge flowing through the target DNA-attached (methylated or 
unmethylated) electrode containing both Faradaic (redox) and non-Faradaic (capacitive) 
charges, and Qdl is the double-layer charge (capacitive charge) from the intercept at t = 0, 
respectively. The redox charge difference (Q) in CC signals between unmethylated and 
methylated was estimated using Eq. 3. 
Chargedifference(∆𝑄) = 𝑄𝑡𝑜𝑡𝑎𝑙,   𝑚𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑒𝑑 − 𝑄𝑡𝑜𝑡𝑎𝑙,   𝑢𝑛𝑚𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑒𝑑 … . … . (3) 
where𝑄𝑡𝑜𝑡𝑎𝑙,   𝑚𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑒𝑑and 𝑄𝑡𝑜𝑡𝑎𝑙,   𝑢𝑛𝑚𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑒𝑑are the CC signalsestimated for the 
unmethylated and methylated samples, respectively. 
 
2.7. Methylation specific-high resolution melting (MS-HRM) curve analysis 
MS-HRM was carried out based on the modified versions of the previously published 
procedure [13]. Briefly, HRM curve analysis was demonstrated on the Rotor-Gene Q 
detection system (Qiagen) using the Rotor-Gene ScreenClust Software. PCR was performed 





bisulfite modified genomic DNA, 2 μL RNase free water and 1 μL of each primer. The 
thermal profile comprised 15 min at 95°C, followed by 50 cycles of 30 seconds at 95°C, 30 
seconds at 61°C and 20 second at 72°C. HRM analyses were carried out at temperature 
ramping from 70-95°C. The normalization of melting curve was performed as previously 
reported[40]. 
 
2.8. Sanger sequencing 
To further confirm the methylation status of FAM134B promoter region, we employed 
Sanger sequencing analysis. The purified DNA was mixed with the primer (12 ng of DNA + 
1 μL of 10 pmol primer in 12 μL of H2O) sequence using the Big Dye Terminator (BDT) 
chemistry Version 3.1 (Applied Biosystems). Sanger sequencing was performed and analyzed 
using a 3730xl Capillary sequencer (Applied Biosystems) under standardised cycling PCR 
conditions in the Australian Genome Research Facility (AGRF, Brisbane).  
 
2.9. Statistical analysis 
Statistical analyses were performed via pairwise comparisons between two conditions using 
student’s t-test. Significance level of the tests was taken at p <0.05. 
 
3. Results and discussion 
3.1 Principle of the quantification of gene specific DNA methylation assay 
We first extracted double stranded (ds)-DNA from the cancer cell lines and clinical tissue 
samples from ESCC patients to demonstrate the working principle of the method. We 
performed a bisulfite conversion step for converting unmethylated cytosines in ds-DNA into 
uracils while methylated cytosines remain unchanged. Then, an asymmetric PCR 





cytosines in the complementary strand would be copied into guanines and uracilsinto 
adenines ensuing guanine-enriched methylated and adenine-enriched unmethylated 
samples.The samples were then directly adsorbed on a SPE-Au electrode surface.The 
adsorbed ss-DNA samples were detected by CC interrogation in presence of an electroactive 
complexRuHex. Here, RuHex cations act as the signaling molecule that binds to the anionic 
phosphate of DNA strands in a stoichiometric manner[41]. Previous studies have clearly 
showed that redox charge of RuHex is quantitatively indicating the amount of DNA strands 
localized at the electrode surface[13,41-42].In the present method, since the adsorption 
strength of DNA bases towards gold differ as A>C>G>T, adenine-enriched unmethylated 
DNA leadsto a higher level of adsorbed DNA on the gold electrode surface in comparison to 
guanine-enriched methylated DNA, resulting in a significant difference in CC signals for 
unmethylated and methylated targets. As schematically presented in Fig.1, methylated DNA 
results in a relatively low level of CC charges(i.e.,a significant charge density/µCcm-2) in 
comparison to that of the unmethylated DNA.  
 
3.2. Synthetic sample design 
Recent studies suggested thatalterations in FAM134B gene havea significantimpact in 
gastrointestinal carcinomas and neurological diseases via regulating its expression patterns 
and cellular autophagy [43-46]. It has also been reported that FAM134B is mutated in 
metastatic lymph node tissues and its DNA copy number significant alteratedin oesophageal 
squamous cell carcinoma tissues [43].In this proof-of-concept study, we have used gold-DNA 
affinity interaction for detecting gene-specific DNA methylation in FAM134Bpromoter 
region containing designated CpG sites located within a length of 48 bases. In order to 





within the promoter region of FAM134B gene which mimic the bisulfite treated and 
asymmetric PCR processed methylated and unmethylated DNA regions. 
 
3.3. Assay Optimization 
The extent of the adsorption of the target DNA on unmodified SPE-Au depends on the 
adsorption condition such as adsorption time, solution pH and amount of DNA. We first 
optimized the adsorption time (5-40 mins) of target DNA samples by measuring the redox 
charge differences between the 10 ng/µL synthetic methylated (11 CpG) and unmethylated (0 
CpG) DNA in a solution of pH 7. As depicted in Fig. 2A, the maximum level of difference in 
charge densities between methylated and unmethylated samples was achieved at 5 min of 
adsorption time and gradually decreases with increasing time. At >20 min of the adsorption 
time, the difference in charge densities is minimum. This can be explained by the fact that 
longer adsorption time led to the saturation of the electrode surface with the methylated and 
unmethylated samples, causing a similar level ofthe surface confined redox process (i.e., 
RuHex localized at electrode) in CCfor both the methylated and unmethylated casesproviding 
two CC signals with almost identical magnitudes. Therefore, 5 min of the adsorption time 
was chosen for all subsequent experiments.  
We further investigated the effect of DNA concentration (2.5-40 ng/µL) on the 
change of the charge densitiesbetween the methylated and unmethylated DNA samplesonto a 
SPE-Auin a solution of pH 7 for 5 min of adsorption.As seen in Fig. 2B, a significant change 
in charge densities (80.24)between methylated and unmethylated samples was found at the 
DNA concentration of 5 ng/µL. The maximum redox charge density difference i.e., 95.54was 
achieved using 10 ng/µL of DNA between these two samples. This is related to the increasing 
level of adsorbed DNA (i.e., larger RuHex redox probes) on the electrode surface with 





densities changes was observed. For example, 40 ng/µL of DNA concentration resulted the 
charge densities changes of 40.34between methylated and unmethylated samples. These 
findings clearly indicate that the amount of DNA at >10 ng/ µL offers almost similar level of 
CC signals for both the methylated and unmethylated sequences. This can be explained by 
the fact that saturation of both sequences on the electrode surface was achieved within 5 min 
of adsorption at higher DNA concentrations which eventually leads to a similar level of redox 
charge densities. Thus, 10 ng/ µL of DNA concentration wasselected as an optimal 
concentration for all subsequent experiments. We then estimated the effect of the pH of the 
solution on the adsorption of target DNA by varying the pH of the solution from 3.0 to 9.5. 
Fig. 2C clearly showed thatthe redox charge density changes between methylated and 
unmethylated DNA samples werefound to be 35.25at pH 3.0. The optimalcharge density 
changes 95.55was achieved at neutral pH (i.e., 7), whereas at >pH = 7.0, a gradual decreases 
in charge density changes was recorded. These results clearly showed that pH of the buffer 
solution influence the competition between DNA and gold electrostatic forces (i.e., inherent 
interaction between DNA bases and gold electrodes). At neutral pH, negative charge of the 
phosphate backbone of DNA is optimal to hinder the adsorption of methylated samples while 
still allowing the unmethylated DNA with higher adenine contents to be adsorbed strongly. 
At basic pH, the gold surface would be more negatively charged and electrostatic repulsion 
with the negatively-charged phosphate backbone of DNA could reduce overall DNA 
adsorption.On the other hand, at the lower pH (3), cytosines and adenine in the target 
sequences would be protonated which could facilitate faster adsorption for methylated and 
unmethylated samples resulting saturation ofboth targets on the gold surface within a very 
short time leading to a reduced level of charge density changes. Therefore, we selected pH 7 






3.4. Synthetic sample analysis 
To evaluate the applicability of our approach for the detection ofvarious level of CpG 
methylation within the promoter region of FAM134Bgene, four synthetic DNA samples 
containing 0, 1, 5 and 11 CpG sites were examined. Fig. 3 shows that the decrease of the 
redox chargedensities is a function of the number of CpG cites. This is due to the decrease of 
the adenine contents with increasing methylated CpG sites in the target sequence (i.e., low 
level of adsorbed DNA leading to the lowering of the charge densities). The linear regression 
equation wasestimated to be y (charge, µCcm-2)= -8.2926 (number ofCpG sites)+103.9with a 
correlation coefficient (R2) of 0.9999. The level of redox charge responses showed in Fig.2 
clearlyindicates that our assay can effectively detect DNA methylation at a single CpG level 
of resolution. A similar result has also been reported previously based on gold-DNA [34]and 
graphene-DNA [40] affinity interaction based approaches.  
 
3.6. Heterogonous sample analysis 
Heterogeneous methylation can arise as a mixture of fully methylated and unmethylated 
DNA in varying proportions in tissue samples from cancer patients[47].A heterogeneous 
mixture of cancer cells may contain both fully unmethylated and methylated DNA like 
imprinted gene H19[48].Accuratequantification of heterogeneous DNA methylation pattern 
plays critical role for the detection and prediction of clinical prognosis in human cancers[47]. 
It is therefore important to screen the degree of methylation pattern in a high background of 
unmethylated DNA samples. To evaluate the assay performance for detecting heterogeneous 
DNA methylation pattern, we analysed the dependence of the CCresponses on various degree 
of methylation. The samples were made by mixing synthetic standards of methylated and 
unmethylated DNA sequences to get 0%, 10%, 25%, 50%, 75%, 90% and 100% methylation, 





to the increasing adenine contents in the target DNA sequences. The linear regression 
equation was found to be y (charge, µCcm-2)= -0.8653 (% methylation)+102.6with a 
correlation coefficient (R2) of 0.9998. A methylation change as low as 10% could be detected 
from 10ng/µL of DNA. This data clearly demonstrate that our approach is sensitive enough in 
detecting methylated DNA in the nanogram regime. It is important to note that this level of 
data was much better than the findings of our previous gold-DNA based approach [34,35], 
and was also comparable to recent approaches [18-22]. 
 
3.7. Gene specific methylation detection and validation in cell line and clinical sample 
To demonstrate a complex biological application, we applied our assay to detect the 
methylationstatus at the eleven CpG sites of the targeted FAM134B promoter which have 
been reported to be methylated in ESCC [40]. Purified DNA amplicons obtained from whole 
genome amplification and Jurkat DNA was used as fully unmethylated DNA and 100% 
methylated control, respectively. For avoiding any PCR bias, we quantified the gene copy 
number prior to PCR amplification [34,35].Purified genomic DNA samples generated from 
three ESSC cell lines were then amplified asymmetrically and analyzed using our approach 
under the optimized conditions, Fig. 5A. As indicated in Fig. 5B and C, significant redox 
charge responses were observed in three cancer cell lines, unmethylated WGA, and 100% 
methylated Jurkat DNA samplessignifying the presence of different percentage of 
methylation. When compared to that of the fully unmethylated WGA and 100% methylated 
Jurkat DNA samples, the level of the total redox charges obtained forthe DNA sequences 
derived from HKESC-4, KYSE-510 and HKESC-1 cell lines indicated that HKESC-4 is 
partially and other two could be highly methylated (i.e., hypermethylated) at FAM134B 
promoter gene. The relative standard deviation (%RSD) over three independent experiments 





These data were validated with MS-HRM curve analysis and Sanger sequencing. As can be 
seen in Fig S1, MS-HRM curve analysis showed that DNA samples derived from HKESC-4 
is partially methylated while KYSE-510 and HKESC-1 DNA samples are hypermethylated. 
Moreover, Sanger sequencing also confirmed the different degree methylation in WGA, 
Jurkat DNA and different ESCC cell lines sample (Fig. S2 and 3). These data clearly indicate 
that the proposed assay could be a useful alternative for detecting FAM134B promoter gene 
methylation in cell-derived samples. 
To further demonstrate the potential utility of our method in analysing clinical 
samples, we extended our assay to analyse eight tissue DNA samples derived from patients 
with primary ESCC. Two oesophageal non-cancerous tissue DNA samples were also used as 
a control (see Experimental for details). As indicated in Fig. 5D, all samples showed different 
degree of methylation. The level of total redox chargeof two normal samples clearly showed 
that these two samples are unmethylated in comparison to that of the WGA and Jurkat DNA 
samples. Similarly, by comparing the level of totalredox charges found for WGA and Jurkat 
DNA samples (Fig. 5C), we can estimate that four DNA samples derived from P5, P6, P7 and 
P8 cancer patients were relatively highly methylated, while P1, P2, P3 and P4 samples were 
partially methylated (i.e., low methylation) at FAM134B promoter gene. We then validated 
our assay performance with well-known MS-HRM curve analysis and Sanger sequencing. As 
can be seen in Fig S1B and C, MS-HRM curve analysis identified almost similar methylation 
level in WGA, N1 and N2 samples. Also, P5, P6, P7 and P8 cancer patients were highly 
methylated with respect to that of P1, P2, P3 and P4 samples. Sanger sequencing also 
confirmed that P5, P6, P7 and P8 samples were relatively highly methylated (see typical 
sequencing data in Fig.S2-S4). Moreover, %RSD over three independent experiments in 
quantifying DNA methylation from clinical samples analysis were found to be <5%. These 





degree of DNA methylation in ESCC tissue samples. Also, our assay is highly reproducibile 
with greater sensitivity and specificity without costly fluorescence labels used in many of 
current methylation detection techniques[49-51]. In addition, validation studies with MS-
HRM curve analysis and Sanger sequencing further suggested that our assay could detect 
DNA methylation in easy and inexpensive way from cancer patients.  
Our method offers several advantages over current methodologies. First, the method 
involves the direct adsorption of target DNA onto an unmodified electrode rather than the 
conventional biosensing approach of using recognition and transduction layers, and hence it 
substantially simplifies the detection method by avoiding the use of complicated chemistries 
underlying each step of the sensor fabrication. It also avoids the use of capture probe as well 
as hybridization step. Second, it circumvents the need for the use of radioactive labels, 
methylation-sensitive restriction enzymes, antibodies, and sequencing analysis. Third, the use 
of commercially available and disposable SPE-Au (containing a three-electrode system) 
successfully eliminates the utilization of typical electrochemical cells, counter and reference 
electrodes thereby offering a relatively inexpensive (∼USD $5 per SPE-Au) platform for 
DNA methylation detection. Moreover, the use of SPE-Au potentially avoids the usual time-
consuming cleaning steps associated with conventional electrodes making the analysis much 
faster. Fourth, the detection step of our proposed assay can take only ten min in total 
(excluding bisulfite treatment and asymmetric PCR steps) to achieve electrochemical readout, 




We have reported a simple and new method for the quantification of targeted FAM134B 





bases with gold. The detection was achieved by simply monitoring their direct adsorption of 
bisulfite-treated and PCR amplified sequences onto a SPE-Au. The adsorption of the DNA 
sequence representing methylated and unmethylated was then quantified via CC interrogation 
of the DNA-bound RuHex complexes. Most importantly, our developed assay can 
successfully quantify FAM134B promoter methylation at varying level in a panel of ESCC 
cell lines and clinical samples from ESCC patients. The analytical performance of our 
method has been shown a good agreement with the data obtained using MS-HRM analysis 
and Sanger sequencing. We anticipated that our approach could be potentially useful for the 
detection of epigenetic biomarker in both clinical diagnostics and research. 
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Fig. 1.Principle of the quantification of gene specific DNA methylation assay. The adenine-
enriched unmethylated ss-DNA adsorbsrelatively larger amount on SPE-Au electrode in 
compare to that of the guanine-enriched methylated ss-DNA. A significant electrochemical 
signals were generated by the CC interrogation of DNA-bound Ru(NH3)6]
3+ complexes.Inset, 
typical CC signalsshowing the adenine-enriched unmethylated DNA that produceshigher CC 
charge in comparison to guanine-enriched methylated DNA. 
 
Fig. 2.The redox charge difference obtained for the adsorption of unmethylated (0 CpG) and 
methylated (11 CpG) DNA sequences at (A) various time (B) concentration and (C) pH of 
the solution. Each data point (A-C) represents the average of three repeat trails, and error bars 
represent the standard deviation of measurements (%RSD = <5% for n = 3). 
 
Fig.3.(A)Typical CC curves for the sample containing 0, 1, 5, 11 CpG site and its 
corresponding background signal. (B)CCreadout represent redox charges of RuHex bound to 
DNA with respect to the designated CpG sites. Each data point represents the average of 
three repeat trails, and error bars represent the standard deviation of measurements (%RSD = 
<5% for n = 3).  
 
Fig.4.(A) TypicalCC curves for the sample containing 0%, 10%, 25%, 50%, 75%, 90% and 
100% and their corresponding background signals. (B) CC readout represents redox charges 
of RuHex bound to DNA with respect to the designated methylation level. Each data point 
represents the average of three repeat trails, and error bars represent the standard deviation of 






Fig. 5.(A) Representative amplified PCR products of FAM134B promoter region in 1.5% 
agarose gel. FAM134B were present in all the samples (2-7) except non template control (8). 
Hundred basepairs DNA ladder is used for comparison. (B) Total redox charges for detecting 
FAM134B promoter region in three oesophageal cancer cell lines and unmethylated WGA 
and Jurkat DNA samples. (C) Typical CC curves fordetecting methylation of FAM134B 
promoter region in three oesophageal cancer cell lines, unmethylated WGA and Jurkat 
DNAand its corresponding background signal, and (D)Total redox charges for detecting 
FAM134B promoter region two normal (N1 and N2) and eight (P1-P8) oesophageal cancer 
tissue samples. Each data point represents the average of three repeat trails, and error bars 
represent the standard deviation of measurements (%RSD = <5% for n = 3).Statistical 
significance was determined by pairwise comparison between 2 conditions using student t-
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